EX-FILING FEES 4 tm2329846d1_ex-filingfees.htm EX-FILING FEES

 

Exhibit 107

Calculation of Filing Fee Tables

 

Form S-8

(Form Type)

 

Aprea Therapeutics, Inc.

(Exact Name of Registrant as Specified in its Charter)

 

Table 1: Newly Registered Securities

 

Security Type

Security

Class

Title

Fee

Calculation

Rule

Amount

Registered(1)

Proposed

Maximum

Offering Price

Per Unit

Maximum

Aggregate

Offering Price

Fee Rate

Amount of

Registration

Fee

Equity

Common Stock, par value

$0.001

Rule 457(c) and Rule

457(h)

106,211(2) $3.7664(3) $400,033.11(3) $0.00014760 $59.04
Total Offering Amounts   $400,033.11   $59.04
Total Fee Offsets(4)       -
Net Fee Due       $59.04

 

(1) Pursuant to Rule 416(a) under the Securities Act of 1933, as amended (the “Securities Act”), this Registration Statement on Form S-8 shall cover any additional shares of common stock, $0.001 par value per share (“Common Stock”) of the Registrant that become issuable under the Aprea Therapeutics, Inc. 2019 Equity Incentive Plan (the “2019 Plan”) by reason of any stock dividend, stock split, recapitalization, or other similar transaction effected without the Registrant’s receipt of consideration which results in an increase in the number of the outstanding shares of Common Stock.

 

(2) Consists of shares of Common Stock under the 2019 Plan.

 

(3) Estimated solely for the purpose of calculating the registration fee pursuant to Rules 457(c) and 457(h) of the Securities Act of 1933, as amended, and based upon the average of the high and low prices of the Registrant’s Common Stock as reported on the Nasdaq on November 3, 2023.

 

(4) The Registrant does not have any fee offsets.